Pacira BioSciences Management

Management criteria checks 2/4

Pacira BioSciences' CEO is Frank Lee, appointed in Jan 2024, has a tenure of less than a year. directly owns 0.018% of the company’s shares, worth €154.61K. The average tenure of the management team and the board of directors is 2.6 years and 5.3 years respectively.

Key information

Frank Lee

Chief executive officer

n/a

Total compensation

CEO salary percentagen/a
CEO tenureless than a year
CEO ownership0.02%
Management average tenure2.6yrs
Board average tenure5.3yrs

Recent management updates

Recent updates


CEO

Frank Lee (56 yo)

less than a year

Tenure

Mr. Frank D. Lee served as an Independent Director at Bolt Biotherapeutics, Inc. since November 2021 until September 2024. He is Independent Director of Bausch Health Companies Inc. from May 14, 2024. He i...


Leadership Team

NamePositionTenureCompensationOwnership
Daryl Gaugler
Chief Operating Officer2.6yrsUS$1.53m0.025%
€ 219.8k
Kristen Williams
Chief Administrative Officer & Secretary10.2yrsUS$1.60m0%
€ 0
David Stack
Advisorless than a yearUS$6.88m0.51%
€ 4.4m
Charles Reinhart
Executive Officerless than a yearUS$1.43m0.059%
€ 513.0k
Jonathan Slonin
Chief Medical Officer3.4yrsUS$1.59m0.028%
€ 242.8k
Frank Lee
CEO & Directorless than a yearno data0.018%
€ 154.6k
Shawn Cross
Chief Financial Officerless than a yearno datano data
Lauren Riker
Principal Accounting Officer & Senior VP of Finance12.8yrsUS$288.82k0.0046%
€ 40.0k
Susan Mesco
Head of Investor Relationsno datano datano data
Anthony Molloy
Chief Legal & Compliance Officer3yrsUS$2.05m0.028%
€ 240.9k
Richard Kahr
Vice President of Human Resources9.4yrsno datano data
Christopher Young
Chief Manufacturing Officer1.7yrsno datano data

2.6yrs

Average Tenure

54yo

Average Age

Experienced Management: 82P's management team is considered experienced (2.6 years average tenure).


Board Members

NamePositionTenureCompensationOwnership
Frank Lee
CEO & Directorless than a yearno data0.018%
€ 154.6k
Laura Brege
Independent Director13.5yrsUS$364.01k0.027%
€ 230.5k
Paul Hastings
Chairman of the Board13.5yrsUS$390.51k0.016%
€ 140.2k
Andreas Wicki
Independent Director18yrsno datano data
Mark Kronenfeld
Independent Director11.5yrsUS$373.01k0.043%
€ 368.0k
Christopher Christie
Independent Director5.3yrsUS$325.01k0.011%
€ 98.4k
Alethia Young
Independent Director1.2yrsUS$427.86k0%
€ 0
Marcelo Bigal
Independent Director1.2yrsUS$426.45k0.011%
€ 91.9k
Abraham Ceesay
Independent Director1.2yrsUS$427.16k0%
€ 0
Mark Froimson
Independent Director7.5yrsUS$349.01k0.020%
€ 172.9k
Michael Yang
Independent Director1.2yrsUS$427.16k0.0043%
€ 37.4k

5.3yrs

Average Tenure

62.5yo

Average Age

Experienced Board: 82P's board of directors are considered experienced (5.3 years average tenure).


Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/26 20:46
End of Day Share Price 2024/12/23 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Pacira BioSciences, Inc. is covered by 34 analysts. 8 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Richard SilverBarclays
Balaji PrasadBarclays
Anita DushyanthBerenberg